BIOMAT Database Logo BIOMAT Database Logo

A case of steroid-resistant nephrotic syndrome associated with systemic lupus erythematosus. 2014

I Ito, and M Nishida, and S Morioka, and T Nozaki, and T Imamura, and A Morimoto, and S Akioka, and T Sugimoto, and K Hamaoka, and H Hosoi
Department of Pediatrics, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan.

We report on an 11-year-old girl who developed steroid-resistant nephrotic syndrome (NS) at the onset of systemic lupus erythematosus (SLE), and clinical and renal histological findings suggested that her NS would be associated with SLE-related podocytopathy. Although initial treatment with intravenous pulse methylprednisolone was ineffective, following treatment with cyclosporine and an angiotensin receptor blocker was effective for her nephrotic proteinuria. She had developed posterior reversible encephalopathy syndrome (PRES), and mycophenolate mofetil (MMF) was started instead of cyclosporine. At present, 45 months after the onset, she is in remission of both NS and SLE. This case indicates that NS associated with SLE-related podocytopathy should be included in the spectrum of glomerulopathy accompanying SLE, also in the pediatric population.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016572 Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400

Related Publications

I Ito, and M Nishida, and S Morioka, and T Nozaki, and T Imamura, and A Morimoto, and S Akioka, and T Sugimoto, and K Hamaoka, and H Hosoi
[A case of systemic lupus erythematosus associated with nephrotic syndrome].
January 1970, Reumatizam,
I Ito, and M Nishida, and S Morioka, and T Nozaki, and T Imamura, and A Morimoto, and S Akioka, and T Sugimoto, and K Hamaoka, and H Hosoi
[A case of systemic lupus erythematosus associated with minimal change nephrotic syndrome].
October 1997, Nihon Jinzo Gakkai shi,
I Ito, and M Nishida, and S Morioka, and T Nozaki, and T Imamura, and A Morimoto, and S Akioka, and T Sugimoto, and K Hamaoka, and H Hosoi
[A case of gastric cancer associated with systemic lupus erythematosus and nephrotic syndrome].
October 2013, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
I Ito, and M Nishida, and S Morioka, and T Nozaki, and T Imamura, and A Morimoto, and S Akioka, and T Sugimoto, and K Hamaoka, and H Hosoi
[Case of systemic lupus erythematosus with isolated nephrotic syndrome].
April 1978, Vrachebnoe delo,
I Ito, and M Nishida, and S Morioka, and T Nozaki, and T Imamura, and A Morimoto, and S Akioka, and T Sugimoto, and K Hamaoka, and H Hosoi
Minimal-change nephrotic syndrome associated with systemic lupus erythematosus.
January 1995, American journal of nephrology,
I Ito, and M Nishida, and S Morioka, and T Nozaki, and T Imamura, and A Morimoto, and S Akioka, and T Sugimoto, and K Hamaoka, and H Hosoi
Minimal change nephrotic syndrome associated with systemic lupus erythematosus.
January 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
I Ito, and M Nishida, and S Morioka, and T Nozaki, and T Imamura, and A Morimoto, and S Akioka, and T Sugimoto, and K Hamaoka, and H Hosoi
[Nephrotic syndrome in systemic lupus erythematosus].
January 1996, Srpski arhiv za celokupno lekarstvo,
I Ito, and M Nishida, and S Morioka, and T Nozaki, and T Imamura, and A Morimoto, and S Akioka, and T Sugimoto, and K Hamaoka, and H Hosoi
[Nephrotic syndrome in systemic lupus erythematosus].
August 1966, Terapevticheskii arkhiv,
I Ito, and M Nishida, and S Morioka, and T Nozaki, and T Imamura, and A Morimoto, and S Akioka, and T Sugimoto, and K Hamaoka, and H Hosoi
[Low-flow priapism associated with systemic lupus erythematosus and nephrotic syndrome].
December 2000, Archivos espanoles de urologia,
I Ito, and M Nishida, and S Morioka, and T Nozaki, and T Imamura, and A Morimoto, and S Akioka, and T Sugimoto, and K Hamaoka, and H Hosoi
NORMOCHOLESTEROLEMIC NEPHROTIC SYNDROME OF SYSTEMIC LUPUS ERYTHEMATOSUS.
February 1964, The American journal of medicine,
Copied contents to your clipboard!